Without treatment, half of people with potentially treatable colon cancer (stages 1 through 3) survive less than 6.8 months, based on a 2021 study of over 7,000 patients who declined surgery. That number stands in sharp contrast to the roughly 24-month median survival among those who did have surgery in the same study. The actual timeline varies enormously depending on stage, tumor location, age, and overall health.
Survival by Stage Without Surgery
Stage is the single biggest factor determining how long untreated colon cancer will progress before it becomes fatal. When colon cancer is still localized (confined to the colon wall), treated patients have a 91.3% five-year survival rate. Regional disease, where cancer has reached nearby lymph nodes, drops to 75.2%. Once cancer has spread to distant organs, the five-year survival rate falls to 16.9%, even with treatment.
Without any treatment, those numbers collapse. A study of people in their 80s and 90s with colon cancer that hadn’t yet spread to distant sites found a two-year survival rate of just 38.9% among those who received only palliative care (symptom management, not curative treatment), compared to 78.9% for those who had surgery. At five years, the gap widened further: 11.3% survival without surgery versus 59.6% with it. These patients had localized or regional disease, the most treatable forms. For someone with distant metastases who refuses all treatment, survival is typically measured in months rather than years.
How Colon Cancer Progresses Without Intervention
Colon cancer begins as a polyp on the inner lining of the colon. The transformation from a harmless polyp to a cancerous growth takes roughly 10 years, according to Cleveland Clinic estimates. That long window is why screening colonoscopies are so effective at catching problems early. But once a polyp has turned cancerous and is left untreated, the timeline accelerates.
An untreated tumor will continue growing through the layers of the colon wall, eventually reaching nearby lymph nodes and then spreading through the bloodstream to distant organs, most commonly the liver and lungs. The speed of this progression depends on the tumor’s biology. Some cancers are slow-growing and may take years to metastasize. Others are aggressive and can spread within months of becoming cancerous.
Where the Tumor Sits Matters
Colon cancers on the right side of the colon (the ascending colon, near where the small intestine connects) tend to behave differently from those on the left side. Right-sided tumors are more likely to be diagnosed at a later stage because they often grow without causing obvious symptoms like bleeding or changes in bowel habits. They also tend to be more genetically aggressive, grow more rapidly, and carry a higher risk of spreading to distant organs. Left-sided tumors, by contrast, are more likely to cause noticeable symptoms earlier, leading to earlier diagnosis, and they generally respond better to available treatments.
For someone choosing not to pursue treatment, a right-sided tumor is more likely to progress quickly and shorten survival compared to a left-sided cancer of the same stage.
The Role of Age and Other Health Conditions
Older age and existing health problems both independently shorten survival in colon cancer. Research published in the Journal of Gastrointestinal Oncology found that each additional year of age increased the risk of death by about 2%, and each additional chronic condition (measured on a standard scoring system) increased risk by roughly 22%. These effects compound: a 55-year-old with no other health problems and an untreated early-stage tumor may survive for years, while an 85-year-old with heart disease, diabetes, and the same cancer may have a much shorter timeline.
This is one reason some elderly patients with serious comorbidities opt against aggressive treatment. The surgery and recovery itself carries risks that may not be worth the potential benefit if life expectancy from other conditions is already limited. In those cases, palliative care focused on comfort and symptom control becomes the primary approach.
What Eventually Causes Death
Untreated colon cancer typically kills through one of several mechanisms, depending on where the cancer grows and spreads. A tumor that keeps enlarging within the colon can eventually block the intestine entirely, causing a bowel obstruction. Food and waste can no longer pass through, leading to severe pain, vomiting, and dangerous swelling. If the blocked bowel wall tears (a perforation), bacteria spill into the abdominal cavity, causing a life-threatening infection called peritonitis. People who develop obstruction or perforation have significantly worse outcomes.
When cancer spreads to the liver, which is the most common site for colon cancer metastases, it gradually replaces healthy liver tissue. As liver function declines, the body loses its ability to filter toxins, produce essential proteins, and manage fluid balance. Liver failure is one of the most common direct causes of death in advanced colon cancer. Spread to the lungs can similarly impair breathing over time. In some cases, the cancer causes severe malnutrition because the body diverts energy to tumor growth while the patient’s ability to eat and absorb nutrients steadily declines.
Palliative Care Versus No Care at All
There’s an important distinction between refusing curative treatment (like surgery or chemotherapy) and refusing all medical care. Palliative care doesn’t aim to cure the cancer, but it can meaningfully extend survival while reducing suffering. Pain management, treatment of bowel obstructions with stents or limited procedures, nutritional support, and management of complications can add months or even years compared to receiving no care whatsoever.
The study of elderly patients described above illustrates this: even without surgery, about 39% of those receiving palliative care were still alive at two years. That’s a far cry from the surgical group’s 79%, but it’s also not zero. For someone who has decided against curative treatment, staying connected to a medical team for symptom management can still make a significant difference in both quality and length of life.